Expression and clinical significance of TAp73α, p53, PCNA and apoptosis in hepatocellular carcinoma

Table 1 Kaplan-Meier for survival.

Factor	n	%	P	Factor	n	%	P
Sex			0.910	Node metastasis			0.197
Female	9	19.15		Positive	8	17.02
Male	38	80.85		Negative	39	82.98
Age (yr)			0.258	PV invasion			0.000b
>45	29	61.7		Positive	7	14.89
≤45	18	38.30		Negative	40		85.11
HBsAg			0.007b	AI			0.938
Positive	44	93.62		<Mean	25	53.19
Negative	3	6.38		>Mean	22	46.81
AFP			0.012a	PI			0.052
<400 mg/L	23	48.94		<Mean	25	53.19
>400 mg/L	24	51.06		>Mean	22	46.81
Size			0.281	p53			0.402
≤5 cm	19	40.43		Negative	29	61.7
>5 cm	28	59.57		Positive	18	38.3
TNM stage			0.002b	TAp73a			0.039a
II	13	27.66		Negative	30	63.83
III+IV	34	72.34		Positive	17	36.17
Differentiation			0.566	Liver membrane invasion			0.014a
Well	39	82.98		Negative	28	59.57
Poor	8	17.02		Positive	19	40.43

^aP<0.05;

^bP<0.01 vs control group.

Table 2 Variables in the equation method = backward stepwise (conditional LR).

	SE	Wald
AFP (>400 mg/L, <400 mg/L)	0.417	8.475
PV invasion (positive, negative)	0.519	5.684
AI (high, low)	0.380	3.495
TAp73a (positive, negative)	0.367	4.323
Liver membrane invasion (y, n)	0.367	8.434
Age (>45, ≤45)	0.392	4.360
TNM stage (II, III+IV)	0.477	6.18